Medicare Plans for Type 2 Diabetes: Finding Coverage for Your Medications

If you have type 2 diabetes, your Medicare plan choice can mean the difference between $12/month for your medications and $400/month — for the exact same drugs. Here's what drives that gap, and how to find a plan that actually covers what you take.

Why Medicare Coverage for Diabetes Medications Varies So Much

Every Medicare Advantage and Part D plan maintains its own formulary — a list of covered drugs organized into tiers, where each tier carries a different copay or coinsurance. There is no single Medicare formulary. Two plans in the same zip code, from the same carrier, at the same premium can cover the exact same medication at wildly different tiers.

For diabetes medications, this variation is especially dramatic because the drug landscape includes everything from decades-old generics (metformin costs pennies to manufacture) to some of the most expensive drugs in the U.S. market (GLP-1 agonists like semaglutide can list above $900/month before insurance).

Plans control costs by:

• Placing drugs on higher tiers, which means higher out-of-pocket costs for you
• Requiring prior authorization, so you must get approval before the plan covers a drug
• Imposing step therapy, where you must try a cheaper drug first before the plan covers a more expensive one
• Setting quantity limits on how much of a drug you can fill per month

Key Formulary Differences: Metformin, Insulin, and GLP-1s

The three main categories of diabetes medications behave very differently across Medicare formularies. Here's what to expect — and watch out for.

Metformin (and other oral generics)

Metformin is the first-line oral medication for type 2 diabetes and has been generic for decades. Nearly every Medicare plan covers it, and most place it at Tier 1 with a $0–$5 copay per fill. If metformin is your only diabetes medication, your plan choice for drug coverage is relatively straightforward — cost differences will come from other medications and from medical cost-sharing.

Other older oral diabetes drugs (glipizide, glimepiride, pioglitazone) are similarly well-covered at low tiers across most plans.

Insulin

Insulin coverage under Medicare improved significantly under the Inflation Reduction Act. Starting in 2023, Medicare Part D plans must cap insulin cost-sharing at $35 per month per covered insulin. This applies to most insulins, including brand-name products like Lantus, Basaglar, Humalog, and Novolog.

The key word is "covered." If your insulin isn't on a plan's formulary, the $35 cap doesn't apply. Always verify your specific insulin product is actually listed in the formulary — don't assume it is because a similar insulin is covered.

Additionally, several insulin products were among the 10 drugs CMS negotiated directly with manufacturers under the IRA, with negotiated prices effective January 1, 2026. Fiasp and NovoLog (both semaglutide-adjacent insulin products) saw significant price reductions — this flows through to lower tier costs in plans that carry them.

GLP-1 Receptor Agonists (Ozempic, Trulicity, Victoza, Rybelsus)

This is where coverage variation is extreme. GLP-1 agonists are the fastest-growing class of diabetes medications and include semaglutide (Ozempic, Rybelsus), dulaglutide (Trulicity), liraglutide (Victoza), and others. They're proven to lower blood sugar, reduce cardiovascular risk, and — in some cases — cause meaningful weight loss.

The problem: they're brand-name drugs with no generic equivalents yet, and their list prices are high. What this means for your formulary:

Tier placements and copays vary by plan and change annually. Verify your specific plan's formulary before enrolling.

How to Compare Plans When You Have Diabetes

Picking a Medicare plan based on the monthly premium is the most common — and most expensive — mistake people with diabetes make. Your prescription drug costs will typically dwarf any premium difference. Here's the right framework:

Step 1: List every medication you take, with dosage and frequency

Be precise. "Ozempic" and "Ozempic 0.5mg weekly" may be on different formulary entries. Some plans cover lower doses at Tier 3 and higher doses at Tier 5. Know exactly what your doctor prescribed.

Step 2: Check each plan's formulary for your specific drugs

Don't assume — look. Every Medicare plan is required to publish its formulary online. You can search Medicare.gov's Plan Finder, or use PlanPilot's comparison tool, which checks formulary coverage automatically when you enter your prescriptions.

For each drug, note: (a) Is it covered? (b) What tier? (c) Are there prior authorization, step therapy, or quantity restrictions?

Step 3: Estimate your annual drug costs, not just monthly premium

A plan with a $50/month premium that places Ozempic at Tier 5 with $195/month cost-sharing is more expensive than a $0-premium plan that covers Ozempic at Tier 3 for $95/month — even before you account for other medications, doctor visits, or deductibles.

Step 4: Verify your endocrinologist and primary care doctor are in-network

For Medicare Advantage plans, your doctors must be in the plan's network or you face much higher out-of-network costs (or no coverage at all in HMO plans). Diabetes management often involves multiple specialists — verify each one.

Step 5: Check the annual out-of-pocket maximum (MOOP)

The $2,000 Part D cap protects you on drugs. But medical cost-sharing (doctor visits, labs, A1C tests, specialist appointments) has its own MOOP. In 2026, CMS caps Medicare Advantage in-network MOOP at $9,350. Some plans set it lower. If your diabetes requires frequent medical care, a lower MOOP may save you thousands — even at a higher premium.

Why Coverage Changes Mid-Year — and What to Do About It

Your Medicare plan's formulary is not locked for the year just because you enrolled. Plans can — and do — change formulary coverage during the plan year. CMS permits mid-year formulary changes under specific conditions:

• Generic substitution: If a brand-name drug you take gets a generic equivalent, the plan can move the brand to a higher tier or remove it from the formulary — usually with 60 days notice.
• Safety-related removals: If FDA issues a safety warning or withdrawal, plans can remove a drug immediately.
• Contract renegotiations: Plans regularly renegotiate pricing with drug manufacturers. If a negotiation fails, a drug's tier can change.

For diabetes patients specifically, this is most likely to affect GLP-1 agonists — they're expensive, under active pricing pressure, and newer to formularies. A plan that covered Ozempic at Tier 3 when you enrolled in January may move it to Tier 5 by June.

What you can do:

• Request an exception if your formulary tier changes and you can document medical necessity for staying on the same drug.
• Use your Special Enrollment Period (SEP) if a plan significantly cuts benefits — you may qualify to switch plans outside the normal Annual Enrollment Period.
• Keep an eye on your Plan Explanation of Benefits — you'll receive notice of formulary changes by mail. Don't ignore these letters.
• Talk to your prescriber about therapeutically equivalent alternatives that might be on lower tiers — sometimes a switch from one GLP-1 to another saves significantly.